TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company,
today announced financial results for the second quarter ended June
30, 2024.
Second Quarter 2024 Highlights
All comparisons are to the quarter ended June 30, 2023, unless
otherwise noted
- Total bookings of $23.3 million compared to $21.0 million
- Total revenue of $84.7 million compared to $84.6 million
- Revenue Cycle Management (RCM) revenue of $54.1 million
compared to $47.8 million
- RCM revenue represented 63.9% of TruBridge’s total revenue
- GAAP (loss) earnings per diluted share of $(0.34) compared to
$(0.20)
- Non-GAAP earnings per diluted share of $0.16 compared to
$0.40
- Adjusted EBITDA of $12.6 million compared to $11.2 million
Chris Fowler, chief executive officer of TruBridge, Inc.,
stated, “We are pleased with our second quarter performance, both
operationally and financially. The team continued to build on our
bookings momentum and cross-selling efforts, while we further
enhanced our financial operations. Our solid revenue performance
and adjusted EBITDA margin expansion in the quarter was punctuated
by a significant improvement in cash flow from operations.
“Given the health of our pipeline and clear line of sight for
the remainder of the year, we are reiterating guidance and are
enthusiastic about our future outlook,” concluded Fowler.
Financial Guidance
For the third quarter of 2024, TruBridge expects to
generate:
- Total revenue between $82 million and $85 million
- Adjusted EBITDA between $11.5 million and $13.5 million
For the full year 2024, TruBridge reiterates prior outlook
of:
- Total revenue between $330 million and $340 million
- Adjusted EBITDA between $45 million and $50 million
Conference Call
TruBridge will hold a conference call and live webcast to
discuss second quarter 2024 results on Thursday, August 8, 2024, at
3:30 p.m. Central time/4:30 p.m. Eastern time. To access this
interactive teleconference, dial (800) 715-9871 and request
connection to the TruBridge earnings conference call. A 30-day
online replay will be available approximately one hour following
the conclusion of the live webcast. To listen to the live webcast
or access the replay, visit the Company’s investor relations
website, investors.trubridge.com.
About TruBridge
We are a trusted partner to more than 1,500 healthcare
organizations with a broad range of technology-first solutions that
address the unique needs and challenges of diverse communities,
promoting equitable access to quality care and fostering positive
outcomes. TruBridge has over four decades of experience in
connecting providers, patients and communities with innovative
data-driven solutions that create real value by supporting both the
financial and clinical side of healthcare delivery. Our industry
leading HFMA Peer Reviewed® suite of revenue cycle management (RCM)
offerings combine unparalleled visibility and transparency to
enhance productivity and support the financial health of healthcare
organizations across all care settings. We support efficient
patient care with electronic health record (EHR) product offerings
that successfully integrate data between care settings. Above all,
we believe in the power of community and encourage collaboration,
connection, and empowerment with our customers. We clear the way
for care. For more information, please visit www.trubridge.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the “safe harbor” provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements can be identified generally by the use of
forward-looking terminology and words such as “expects,”
“anticipates,” “estimates,” “believes,” “predicts,” “intends,”
“plans,” “potential,” “may,” “continue,” “should,” “will” and words
of comparable meaning. Without limiting the generality of the
preceding statement, all statements in this press release relating
to the Company’s future financial and operational results are
forward-looking statements. We caution investors that any such
forward-looking statements are only predictions and are not
guarantees of future performance. Certain risks, uncertainties and
other factors may cause actual results to differ materially from
those projected in the forwardlooking statements. Such factors may
include: saturation of our target market and hospital
consolidations; unfavorable economic or market conditions that may
cause a decline in spending for information technology and
services; significant legislative and regulatory uncertainty in the
healthcare industry; exposure to liability for failure to comply
with regulatory requirements; pandemics and other public health
crises and related economic disruptions; transition to a
subscription-based recurring revenue model and modernization of our
technology; competition with companies that have greater financial,
technical and marketing resources than we have; potential future
acquisitions that may be expensive, time consuming, and subject to
other inherent risks; our ability to attract and retain qualified
client service and support personnel; disruption from periodic
restructuring of our sales force; potential delay in the
development of markets for our RCM service offering; potential
inability to properly manage growth in new markets we may enter;
potential disruption of our business due to our ongoing
implementation of a new enterprise resource planning software
solution; exposure to numerous and often conflicting laws,
regulations, policies, standards or other requirements through our
international business activities; potential litigation against us;
our reliance on an international workforce which exposes us to
various business disruptions; our utilization of artificial
intelligence, which could expose us to liability or adversely
affect our business if we cannot compete effectively with others
using artificial intelligence; potential failure to develop new
products or enhance current products that keep pace with market
demands; failure of our products to function properly resulting in
claims for medical and other losses; breaches of security and
viruses in our systems resulting in customer claims against us and
harm to our reputation; failure to maintain customer satisfaction
through new product releases free of undetected errors or problems;
failure to convince customers to migrate to current or future
releases of our products; failure to maintain our margins and
service rates; increase in the percentage of total revenues
represented by service revenues, which have lower gross margins;
exposure to liability in the event we provide inaccurate claims
data to payors; exposure to liability claims arising out of the
licensing of our software and provision of services; dependence on
licenses of rights, products and services from third parties;
misappropriation of our intellectual property rights and potential
intellectual property claims and litigation against us;
interruptions in our power supply and/or telecommunications
capabilities, including those caused by natural disaster; potential
inability to secure additional financing on favorable terms to meet
our future capital needs; our substantial indebtedness, and our
ability to incur additional indebtedness in the future; pressures
on cash flow to service our outstanding debt; restrictive terms of
our credit agreement on our current and future operations; changes
in and interpretations of financial accounting matters that govern
the measurement of our performance; significant charges to earnings
if our goodwill or intangible assets become impaired; fluctuations
in quarterly financial performance due to, among other factors,
timing of customer installations; volatility in our stock price;
failure to maintain effective internal control over financial
reporting; inherent limitations in our internal control over
financial reporting; vulnerability to significant damage from
natural disasters; market risks related to interest rate changes;
potential material adverse effects due to macroeconomic conditions,
including bank failures or changes in related regulation; and other
risk factors described from time to time in our public releases and
reports filed with the Securities and Exchange Commission,
including, but not limited to, our most recent Annual Report on
Form 10-K and our Quarterly Report on Form 10-Q for the quarter
ended June 30, 2024. We also caution investors that the
forward-looking information described herein represents our outlook
only as of this date, and we undertake no obligation to update or
revise any forward-looking statements to reflect events or
developments after the date of this press release.
TruBridge, Inc. Condensed Consolidated Statements of Income (In
'000s, except per share data) (Unaudited) Three Months Ended
June 30, Six Months Ended June 30,
2024
2023
2024
2023
Revenues RCM
$
54,108
$
47,760
$
107,146
$
96,391
EHR
30,622
36,862
60,831
74,464
Total revenues
84,730
84,622
167,977
170,855
Expenses Costs of revenue (exclusive of amortization
and depreciation) RCM
30,269
27,119
59,866
54,302
EHR
13,073
17,014
25,237
34,008
Total costs of revenue (exclusive of amortization and depreciation)
43,342
44,133
85,103
88,310
Product development
8,207
8,769
18,894
17,121
Sales and marketing
7,815
8,132
14,408
15,089
General and administrative
18,878
19,057
38,274
33,510
Amortization
9,107
5,858
14,975
11,341
Depreciation
400
579
800
1,095
Total expenses
87,749
86,528
172,454
166,466
Operating income (loss)
(3,019
)
(1,906
)
(4,477
)
4,389
Other income (expense): Other income
91
78
1,514
346
Interest expense
(4,242
)
(2,664
)
(8,315
)
(5,334
)
Total other expense
(4,151
)
(2,586
)
(6,801
)
(4,988
)
Loss before taxes
(7,170
)
(4,492
)
(11,278
)
(599
)
Income tax benefit
(2,121
)
(1,655
)
(3,713
)
(846
)
Net income (loss)
$
(5,049
)
$
(2,837
)
$
(7,565
)
$
247
Net income (loss) per common share—basic
$
(0.34
)
$
(0.20
)
$
(0.51
)
$
0.02
Net income (loss) per common share—diluted
$
(0.34
)
$
(0.20
)
$
(0.51
)
$
0.02
Weighted average shares outstanding used in per common
share computations: Basic
14,313
14,200
14,273
14,168
Diluted
14,313
14,200
14,273
14,168
TruBridge, Inc. Condensed Consolidated Balance Sheets (In '000s,
except per share data) June 30, 2024(Unaudited) Dec. 31,
2023
Assets Current assets Cash and cash equivalents
$
7,709
$
3,848
Accounts receivable, net of allowance for expected credit losses of
$3,315 and $3,631, respectively
59,603
59,723
Financing receivables, current portion (net of allowance for
expected credit losses of $332 and $319, respectively)
4,137
3,997
Inventories
793
475
Prepaid income taxes
2,307
1,628
Prepaid expenses and other
17,034
15,807
Assets of held for sale disposal group
-
25,977
Total current assets
91,583
111,455
Property & equipment, net
8,479
8,974
Software development costs, net
39,741
39,139
Operating lease assets
3,861
5,192
Financing receivables, net of current portion (net of allowance for
expected credit losses of $56 and $97, respectively)
607
1,226
Other assets, net of current portion
8,337
7,314
Intangible assets, net
82,960
89,213
Goodwill
172,573
171,909
Deferred tax assets
4,146
-
Total assets
$
412,287
$
434,422
Liabilities & Stockholders' Equity Current
liabilities Accounts payable
$
15,854
$
10,133
Current portion of long-term debt
3,074
3,141
Deferred revenue
9,842
8,677
Accrued vacation
5,458
5,410
Liabilities of held for sale disposal group
-
977
Other accrued liabilities
17,481
19,892
Total current liabilities
51,709
48,230
Long-term debt, net of current portion
176,964
195,270
Operating lease liabilities, net of current portion
2,512
3,074
Deferred tax liabilities
-
1,230
Total liabilities
231,185
247,804
Stockholders' Equity Common stock, $0.001 par value; 30,000
shares authorized; 15,561 and 15,121 shares issued, respectively
15
15
Treasury stock, 615 and 572 shares, respectively
(17,434
)
(17,075
)
Accumulated other comprehensive gain
108
-
Additional paid-in capital
197,846
195,546
Retained earnings
567
8,132
Total stockholders' equity
181,102
186,618
Total liabilities and stockholders' equity
$
412,287
$
434,422
TruBridge, Inc. Condensed Consolidated Statements of Cash Flows (In
'000s) (Unaudited) Six Months Ended June 30,
2024
2023
Operating activities: Net income (loss)
$
(7,565
)
$
247
Adjustments to net income (loss): Provision for credit losses
358
181
Deferred taxes
(5,224
)
(1,533
)
Stock-based compensation
2,300
1,124
Depreciation
800
1,095
Gain on sale of business
(1,250
)
-
Amortization of acquisition-related intangibles
6,253
8,029
Amortization of software development costs
8,722
3,312
Amortization of deferred finance costs
213
180
Non-cash operating lease costs
897
1,211
Loss on disposal of property and equipment
-
117
Changes in operating assets and liabilities: Accounts receivable
654
(3,806
)
Financing receivables
506
940
Inventories
(318
)
(178
)
Prepaid expenses and other
1,502
(2,017
)
Accounts payable
5,750
7,448
Deferred revenue
1,769
(1,705
)
Operating lease liabilities
(583
)
(1,067
)
Other liabilities
(2,375
)
(2,278
)
Prepaid income taxes
(679
)
(1,110
)
Net cash provided by operating activities
11,730
10,190
Investing activities: Purchase of business, net of
cash acquired
(664
)
-
Sale of business, net of cash and cash equivalents sold
21,410
-
Investment in software development
(9,324
)
(12,143
)
Purchases of property and equipment
(306
)
(72
)
Net cash provided by (used in) investing activities
11,116
(12,215
)
Financing activities: Treasury stock purchases
(358
)
(2,532
)
Payments of long-term debt principal
(5,750
)
(1,750
)
Proceeds from revolving line of credit
21,072
11,602
Payments of revolving line of credit
(33,379
)
(5,000
)
Debt issuance cots
(529
)
-
Net cash provided by (used in) financing activities
(18,944
)
2,320
Increase in cash and cash equivalents
3,902
295
Change in cash and cash equivalents included in assets sold
(41
)
Cash and cash equivalents, beginning of period
3,848
6,951
Cash and cash equivalents, end of period
$
7,709
$
7,246
TruBridge, Inc. Consolidated Bookings (In '000s) (Unaudited)
(Non-GAAP) Three Months Ended June 30, Six Months Ended June
30, In '000s
2024
2023 (3)
2024
2023 (3)
RCM(1)
$
13,458
$
13,648
$
27,849
$
25,748
EHR(2)
9,832
7,322
19,010
15,069
Total
$
23,290
$
20,970
$
46,859
$
40,817
(1)
Generally calculated as the total
contract price (for non-recurring, project-related amounts) and
annualized contract value (for recurring amounts).
(2)
Generally calculated as the total
contract price (for system sales) and annualized contract value
(for support) for perpetual license system sales and total contract
price for SaaS sales.
(3)
Adjustment was made to the 2023
bookings, due to 3rd Party Software, and Forms and Supplies being
doubled accounted for in the total EHR bookings.
TruBridge, Inc. Bookings Composition (In '000s, except per share
data) (Unaudited) (Non-GAAP) Three Months Ended June 30, Six
Months Ended June 30,
2024
2023 (3)
2024
2023 (3)
RCM Net new(1)
$
6,453
$
3,395
$
15,446
$
9,749
Cross-sell(1)
7,004
10,253
12,402
15,999
EHR Non-subscription sales(2)
4,084
4,458
7,534
10,506
Subscription revenue(3)
5,749
2,864
11,477
4,563
Total
$
23,290
$
20,970
$
46,859
$
40,817
(1)
“Net new” represents bookings
from outside the Company’s core EHR client base, and “Cross-sell”
represents bookings from existing EHR customers. In each case, such
bookings are generally comprised of recurring revenues to be
recognized ratably over a one-year period and an average timeframe
for commencement of bookings-to-revenue conversion of four to six
months following contract execution.
(2)
Represents nonrecurring revenues
that generally exhibit a timeframe for bookings-to-revenue
conversion of five to six months following contract execution.
(3)
Represents recurring revenues to
be recognized on a monthly basis over a weighted-average contract
period of five years, with a start date in the next 12 months and
an average timeframe for commencement of bookings-to-revenue
conversion of five to six months following contract execution.
TruBridge, Inc. Adjusted EBITDA - by Segment (In '000s) (Unaudited)
(Non-GAAP) Three Months Ended June 30, Six Months Ended June
30, In '000s
2024
2023
2024
2023
RCM
$
7,804
$
5,682
$
14,202
$
13,580
EHR
4,770
5,545
7,826
12,289
Total
$
12,574
$
11,227
$
22,028
$
25,869
TruBridge, Inc. Reconciliation of Non-GAAP Financial Measures (In
'000s) (Unaudited) Three Months Ended June 30, Six Months
Ended June 30,
Adjusted EBITDA:
2024
2023
2024
2023
Net income (loss), as reported
$
(5,049
)
$
(2,837
)
$
(7,565
)
$
247
Net Income Margin
(6.0
%)
(3.4
%)
(4.5
%)
0.1
%
Depreciation expense
400
597
800
1,095
Amortization of software development costs
5,980
1,826
8,722
3,312
Amortization of acquisition-related intangibles
3,126
4,014
6,253
8,029
Stock-based compensation
1,501
(123
)
2,300
1,124
Severance and other non-recurring charges
4,586
6,819
8,430
7,920
Interest expense
4,151
2,586
8,051
4,988
Gain on sale of AHT
-
-
(1,250
)
-
Provision (benefit) for income taxes
(2,121
)
(1,655
)
(3,713
)
(846
)
Total Adjusted EBITDA
$
12,574
$
11,227
$
22,028
$
25,869
Adjusted EBITDA Margin
14.8
%
13.3
%
13.1
%
15.1
%
TruBridge, Inc. Reconciliation of Non-GAAP Financial Measures (In
'000s, except per share data) (Unaudited) Three Months Ended
June 30, Six Months Ended June 30,
Non-GAAP Net Income and
Non-GAAP EPS:
2024
2023
2024
2023
Net income (loss), as reported
$
(5,049
)
$
(2,837
)
$
(7,565
)
$
247
Pre-tax adjustments for Non-GAAP EPS: Amortization of
acquisition-related intangible assets
3,126
4,014
6,253
8,029
Stock-based compensation
1,501
(123
)
2,300
1,124
Severance and other nonrecurring charges
4,586
6,819
8,430
7,920
Non-cash interest expense
107
90
213
180
After-tax adjustments for Non-GAAP EPS: Tax-effect of pre-tax
adjustments, at 21%
(1,957
)
(2,269
)
(3,611
)
(3,623
)
Tax shortfall (windfall) from stock-based compensation
4
7
113
57
Non-GAAP net income
$
2,318
$
5,701
$
6,133
$
13,934
Weighted average shares outstanding, diluted
14,313
14,200
14,273
14,168
Non-GAAP EPS
$
0.16
$
0.40
$
0.43
$
0.98
TruBridge, Inc. Electronic Health Record (EHR) Revenue Composition
(In '000s) (Unaudited) Three Months Ended June 30, Six
Months Ended June 30,
2024
2023
2024
2023
Recurring revenues - EHR Acute Care EHR
$
26,666
$
30,013
$
54,160
$
59,353
Post-acute Care EHR
-
3,729
582
7,636
Total recurring revenues - EHR
26,666
33,742
54,742
66,989
Non-recurring revenues - EHR Acute Care EHR
3,956
2,775
6,008
6,750
Post-acute Care EHR
-
345
81
725
Total non-recurring revenues - EHR
3,956
3,120
6,089
7,475
Total EHR revenues
$
30,622
$
36,862
$
60,831
$
74,464
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with accounting
principles generally accepted in the United States of America, or
“GAAP.” However, management believes that, in order to properly
understand our short-term and long-term financial and operational
trends, investors may wish to consider the impact of certain
non-cash or non-recurring items, when used as a supplement to
financial performance measures that are prepared in accordance with
GAAP. These items result from facts and circumstances that vary in
frequency and impact on continuing operations. Management uses
these non-GAAP financial measures in order to evaluate the
operating performance of the Company and compare it against past
periods, make operating decisions, and serve as a basis for
strategic planning. These non-GAAP financial measures provide
management with additional means to understand and evaluate the
operating results and trends in our ongoing business by eliminating
certain non-cash expenses and other items that management believes
might otherwise make comparisons of our ongoing business with prior
periods more difficult, obscure trends in ongoing operations, or
reduce management’s ability to make useful forecasts. In addition,
management understands that some investors and financial analysts
find these non-GAAP financial measures helpful in analyzing our
financial and operational performance and comparing this
performance to our peers and competitors.
As such, to supplement the GAAP information provided, we present
in this press release and during the live webcast discussing our
financial results the following non-GAAP- financial measures:
Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net income, and
Non-GAAP earnings per share (“EPS”).
We calculate each of these non-GAAP financial measures as
follows:
- Adjusted EBITDA – Adjusted EBITDA
consists of GAAP net income as reported and adjusts for (i)
depreciation expense; (ii) amortization of software development
costs; (iii) amortization of acquisition-related intangibles; (iv)
stock-based compensation; (v) severance and other nonrecurring
charges; (vi) interest expense; (vii) gain on sale of AHT; and
(xiii) the provision (benefit) for income taxes.
- Adjusted EBITDA Margin – Adjusted
EBITDA Margin is calculated as Adjusted EBITDA, as defined above,
divided by total revenue.
- Non-GAAP net income – Non-GAAP net
income consists of GAAP net income as reported and adjusts for (i)
amortization of acquisition-related intangible assets; (ii)
stock-based compensation; (iii) severance and other non-recurring
charges; (iv) non-cash interest expense; (v) gain on sale of AHT;
and (vi) the total tax effect of items (i) through (v).
- Non-GAAP EPS – Non-GAAP EPS
consists of Non-GAAP net income, as defined above, divided by
weighted average shares outstanding (diluted) in the applicable
period.
Certain of the items excluded or adjusted to arrive at these
non-GAAP financial measures are described below:
- Amortization of acquisition-related
intangibles – Acquisition-related amortization expense is a
non-cash expense arising primarily from the acquisition of
intangible assets in connection with acquisitions or investments.
We exclude acquisition-related amortization expense from non-GAAP
financial measures because we believe (i) the amount of such
expenses in any specific period may not directly correlate to the
underlying performance of our business operations and (ii) such
expenses can vary significantly between periods as a result of new
acquisitions and full amortization of previously acquired
intangible assets. Investors should note that the use of these
intangible assets contributed to revenue in the periods presented
and will contribute to future revenue generation, and the related
amortization expense will recur in future periods.
- Stock-based compensation –
Stock-based compensation expense is a non-cash expense arising from
the grant of stock-based awards. We exclude stock-based
compensation expense from non-GAAP financial measures because we
believe (i) the amount of such expenses in any specific period may
not directly correlate to the underlying performance of our
business operations and (ii) such expenses can vary significantly
between periods as a result of the timing and valuation of grants
of new stock-based awards, including grants in connection with
acquisitions. Investors should note that stock-based compensation
is a key incentive offered to employees whose efforts contributed
to the operating results in the periods presented and are expected
to contribute to operating results in future periods, and such
expense will recur in future periods.
- Severance and other nonrecurring
charges – Non-recurring charges relate to certain severance
and other charges incurred in connection with activities that are
considered non-recurring. We exclude non-recurring expenses
(primarily related to costs associated with our recent business
transformation initiative and transaction-related costs) from
non-GAAP financial measures because we believe (i) the amount of
such expenses in any specific period may not directly correlate to
the underlying performance of our business operations and (ii) such
expenses can vary significantly between periods.
- Non Cash Interest expense –
Non-cash interest expense includes amortization of deferred debt
issuance costs. We exclude non-cash interest expense from non-GAAP
financial measures because we believe these non-cash amounts relate
to specific transactions and, as such, may not directly correlate
to the underlying performance of our business operations.
- Interest expense: Interest
incurred on our term loan and revolving credit facility.
- Gain on sale of AHT: Represents
the excess of proceeds received over the net assets sold from our
sale of AHT, our previously wholly-owned post-acute business, in
January 2024.
- Tax shortfall (windfall) from stock-based
compensation – ASU 2016-09, Improvements to Employee
Share-Based Payment Accounting, became effective for the Company
during the third quarter of 2017 and changes the treatment of tax
shortfall and excess tax benefits arising from stock based
compensation arrangements. Prior to ASU 2016-09, these amounts were
recorded as an increase (for excess benefits) or decrease (for
shortfalls) to additional paid-in capital. With the adoption of ASU
2016-09, these amounts are now captured in the period’s income tax
expense. We exclude this component of income tax expense from
non-GAAP financial measures because we believe (i) the amount of
such expenses or benefits in any specific period may not directly
correlate to the underlying performance of our business operations;
and (ii) such expenses or benefits can vary significantly between
periods as a result of the valuation of grants of new stock-based
awards, the timing of vesting of awards, and periodic movements in
the fair value of our common stock.
Management considers these non-GAAP financial measures to be
important indicators of our operational strength and performance of
our business and a good measure of our historical operating trends,
in particular the extent to which ongoing operations impact our
overall financial performance. In addition, management may use
Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure
the achievement of performance objectives under the Company’s stock
and cash incentive programs. Note, however, that these non-GAAP
financial measures are performance measures only, and they do not
provide any measure of cash flow or liquidity. Non-GAAP financial
measures are not alternatives for measures of financial performance
prepared in accordance with GAAP and may be different from
similarly titled non-GAAP measures presented by other companies,
limiting their usefulness as comparative measures. Non-GAAP
financial measures have limitations in that they do not reflect all
of the amounts associated with our results of operations as
determined in accordance with GAAP. Additionally, there is no
certainty that we will not incur expenses in the future that are
similar to those excluded in the calculations of the non-GAAP
financial measures presented in this press release. Investors and
potential investors are encouraged to review the “Unaudited
Reconciliation of Non-GAAP Financial Measures” above.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240808342375/en/
Investor Relations Contact Asher Dewhurst, ICR Westwicke
TBRGIR@westwicke.com
Media Contact Tracey Schroeder Chief Marketing Officer
Tracey.schroeder@trubridge.com (251) 639-8100
TruBridge (NASDAQ:TBRG)
Historical Stock Chart
From Oct 2024 to Nov 2024
TruBridge (NASDAQ:TBRG)
Historical Stock Chart
From Nov 2023 to Nov 2024
